Blockchain Registration Transaction Record

NeuroOne Debuts OneRF® Trigeminal Ablation System at ASSFN 2026

NeuroOne Medical Technologies presents OneRF® Trigeminal Nerve Ablation System and SEEG-Drug Delivery System at ASSFN 2026, advancing treatment for chronic pain and neurological disorders.

This news matters because it signals the advancement of minimally invasive treatments for chronic facial pain and neurological disorders. The OneRF® Trigeminal Nerve Ablation System offers a more precise and efficient approach to radiofrequency lesioning, potentially reducing procedure times and improving patient comfort. Additionally, NeuroOne's SEEG-Drug Delivery System could revolutionize how drugs are delivered to the brain, enabling targeted therapy alongside recording and stimulation. For patients, these innovations promise less invasive surgeries, faster recovery, and better outcomes. For the medical community, they represent a step forward in integrating diagnostic and therapeutic capabilities, ultimately enhancing the standard of care in functional neurosurgery.